Pier Capital LLC Acquires 20,774 Shares of LHC Group, Inc. (NASDAQ:LHCG)

Pier Capital LLC lifted its holdings in LHC Group, Inc. (NASDAQ:LHCGGet Rating) by 31.6% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 86,470 shares of the health services provider’s stock after acquiring an additional 20,774 shares during the period. LHC Group makes up approximately 1.3% of Pier Capital LLC’s portfolio, making the stock its 25th biggest position. Pier Capital LLC’s holdings in LHC Group were worth $11,866,000 at the end of the most recent quarter.

Other hedge funds have also bought and sold shares of the company. Sivik Global Healthcare LLC bought a new stake in LHC Group in the 3rd quarter valued at about $2,354,000. William Blair Investment Management LLC increased its position in LHC Group by 1.2% in the 3rd quarter. William Blair Investment Management LLC now owns 256,956 shares of the health services provider’s stock valued at $40,319,000 after buying an additional 3,026 shares in the last quarter. Janus Henderson Group PLC increased its position in LHC Group by 63.6% in the 3rd quarter. Janus Henderson Group PLC now owns 9,392 shares of the health services provider’s stock valued at $1,474,000 after buying an additional 3,651 shares in the last quarter. CI Investments Inc. increased its position in LHC Group by 26.1% in the 3rd quarter. CI Investments Inc. now owns 19,952 shares of the health services provider’s stock valued at $3,131,000 after buying an additional 4,132 shares in the last quarter. Finally, Mutual of America Capital Management LLC increased its position in LHC Group by 24.0% in the 4th quarter. Mutual of America Capital Management LLC now owns 75,413 shares of the health services provider’s stock valued at $10,349,000 after buying an additional 14,574 shares in the last quarter. 89.65% of the stock is owned by hedge funds and other institutional investors.

LHC Group stock traded down $0.35 during trading on Tuesday, hitting $165.37. The stock had a trading volume of 572,543 shares, compared to its average volume of 539,648. LHC Group, Inc. has a 1 year low of $108.42 and a 1 year high of $223.63. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.06 and a current ratio of 1.41. The company’s 50 day moving average price is $158.41. The firm has a market cap of $5.13 billion, a PE ratio of 51.36, a price-to-earnings-growth ratio of 2.19 and a beta of 0.45.

LHC Group (NASDAQ:LHCGGet Rating) last posted its quarterly earnings data on Wednesday, May 4th. The health services provider reported $1.09 EPS for the quarter, beating the consensus estimate of $1.05 by $0.04. LHC Group had a return on equity of 10.11% and a net margin of 4.44%. The business had revenue of $571.50 million for the quarter, compared to the consensus estimate of $573.10 million. During the same quarter in the prior year, the business earned $1.39 earnings per share. LHC Group’s revenue for the quarter was up 8.9% on a year-over-year basis. On average, sell-side analysts predict that LHC Group, Inc. will post 5.76 EPS for the current fiscal year.

LHCG has been the subject of a number of analyst reports. Credit Suisse Group downgraded LHC Group from an “outperform” rating to a “neutral” rating and cut their price target for the company from $181.00 to $170.00 in a research note on Wednesday, March 30th. Stephens downgraded LHC Group from an “overweight” rating to an “equal weight” rating in a research note on Wednesday, March 30th. Barclays lifted their price target on LHC Group from $154.00 to $170.00 and gave the company an “equal weight” rating in a research note on Tuesday, April 12th. William Blair downgraded LHC Group from an “outperform” rating to a “market perform” rating in a research note on Tuesday, March 29th. Finally, StockNews.com initiated coverage on LHC Group in a research note on Thursday, March 31st. They set a “hold” rating for the company. Thirteen investment analysts have rated the stock with a hold rating, Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $164.20.

LHC Group Company Profile (Get Rating)

LHC Group, Inc, a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. It operates through five segments: Home Health Services, Hospice Services, Home and Community-Based Services, Facility-Based Services, and Healthcare Innovations (HCI).

Featured Articles

Want to see what other hedge funds are holding LHCG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LHC Group, Inc. (NASDAQ:LHCGGet Rating).

Institutional Ownership by Quarter for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.